Related Experiment Video
Updated: Jun 6, 2026
05:44
Rodent Inferior Vena Cava Venoplasty Balloon Model
Published on: May 24, 2024
Interleukin-6: a potential target for post-thrombotic syndrome.
Brandon M Wojcik1, Shirley K Wrobleski, Angela E Hawley
1Section of Vascular Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI, USA.
Annals of Vascular Surgery
|December 7, 2010
Summary
Neutralizing interleukin-6 (IL-6) in a mouse model of deep vein thrombosis (DVT) reduced vein wall fibrosis and collagen deposition. This suggests IL-6 is a potential therapeutic target for preventing post-thrombotic syndrome (PTS).
Area of Science:
- Vascular Biology
- Immunology
- Fibrosis Research
Background:
- Deep vein thrombosis (DVT) and post-thrombotic syndrome (PTS) are significant health issues.
- PTS involves vein wall fibrosis, and elevated Interleukin-6 (IL-6) is linked to both DVT risk and fibrosis.
- The role of IL-6 in vein wall fibrosis progression following DVT requires further elucidation.
Purpose of the Study:
- To investigate the role of IL-6 in the development of vein wall fibrosis using a mouse model of DVT.
- To determine if neutralizing IL-6 can mitigate fibrotic changes associated with DVT.
Main Methods:
- A DVT mouse model was established using inferior vena cava ligation.
- Mice were treated with anti-IL-6 monoclonal antibody or control immunoglobulin G.
- Evaluated thrombus weight, gene/protein expression (IL-6, CCL2), inflammatory cell infiltration, and vein wall morphometrics at various time points.
Main Results:
- Anti-IL-6 treatment led to smaller thrombus weights and reduced CCL2 expression/protein at day 2.
- Monocyte recruitment into the vein wall was impaired from days 2 to 6 in the anti-IL-6 group.
- Intimal thickness was reduced by 44% and collagen deposition by 30% at day 14 with anti-IL-6 treatment.
Conclusions:
- Neutralizing IL-6 during venous thrombogenesis effectively reduced CCL2 production and monocyte recruitment.
- IL-6 neutralization significantly decreased vein wall intimal thickness and fibrosis.
- These findings indicate IL-6 as a potential therapeutic target for preventing fibrotic complications of PTS.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:25Acute Inflammation III: Local and Systemic Effects
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...